億緯鋰能(300014.SZ):擬使用募集資金向惠州億緯動力提供借款 用於乘用車動力電池項目(三期)
格隆匯5月17日丨億緯鋰能(300014.SZ)公佈,公司於2022年5月17日召開的第五屆董事會第四十八次會議審議通過了《關於使用募集資金向惠州億緯動力提供借款用於實施募投項目的議案》,同意公司將募投項目“面向TWS應用的豆式鋰離子電池項目”“面向胎壓測試和物聯網應用的高温鋰錳電池項目”的剩餘資金(不超過12.5億元,含累計利息和現金管理收益等,具體金額以實際結轉時募集資金專户餘額為準)向公司下屬公司惠州億緯動力電池有限公司(“惠州億緯動力”)提供借款,用於實施“乘用車動力電池項目(三期)”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.